Detalles de la búsqueda
1.
Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer;
70(7): e30350, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129114
2.
Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia.
Pediatr Blood Cancer;
70(11): e30634, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592363
3.
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Lancet Oncol;
21(1): 145-161, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786124
4.
The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma.
Pediatr Blood Cancer;
67(1): e28031, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31612589
5.
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study.
J Clin Oncol;
: JCO2301989, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38603641
6.
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report.
Clin Cancer Res;
29(8): 1546-1556, 2023 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749880
7.
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.
J Natl Cancer Inst;
114(8): 1167-1175, 2022 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552709
8.
Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Eur J Cancer;
133: 112-119, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32492633
9.
Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).
Eur J Cancer;
112: 66-79, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30947024
10.
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.
Cancer Med;
8(14): 6437-6448, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31456361
11.
Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.
J Clin Oncol;
: JCO1800076, 2018 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30335557
Resultados
1 -
11
de 11
1
Próxima >
>>